Solventum Corporation
SOLVStock
$81.70+6.37%52W
Market Cap$13.57B
P/E8.72x
Div yield—
Beta0.66
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-16.43%
Price vs S&P 500 (4W)1.77%
VGM Score53.90
Market Capitalization$13.57B
P/E Ratio (Annual)8.72x
Earnings Surprise History
Q1 261.48est. 1.38
Analyst Recommendations
Apr 2026
May 2026
Jun 2026
Jul 2026
3.67
3.67
3.73
3.73
Industry Peers — Surgical & Medical Instruments(141)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
SOLVSolventum Corporation | C | D | B | $81.70 |
| SYKStryker Corporation | C | C | D | $331.20 |
| MMM3M Company | C | F | B | $161.77 |
| BSXBoston Scientific Corp. | C | B | F | $44.62 |
| MDLNMedline Inc. Class A common stock | C | D | D | $41.11 |
| BDXBecton, Dickinson and Co. | B | C | B | $159.93 |
| DXCMDexCom, Inc. | C | B | C | $77.98 |
| RMDResMed Inc. | C | B | D | $202.76 |
| WSTWest Pharmaceutical Services, Inc. | D | C | A | $362.44 |
| PENPenumbra, Inc. | F | C | B | $319.60 |
| BAXBaxter International Inc. | B | F | C | $23.35 |
About
Solventum is a diversified healthcare company providing innovative medical solutions across three core areas: wound care and surgical supplies, dental products, and health information systems. The company leverages material science, data science, and digital technologies to serve hospitals, dental practices, and healthcare providers. Solventum generates the majority of its revenue in the United States while maintaining a growing international presence.